Skip to main content
大禹生物 logo

大禹生物 — Investor Relations & Filings

Ticker · 920970 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 384 across all filing types
Latest filing 2026-01-13 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920970

About 大禹生物

http://www.sxdysw.cn/

Shanxi Dayu Biological Assistance Co., Ltd. specializes in the research, development, and production of advanced animal nutrition and health solutions. The company focuses on the manufacturing of feed additives, micro-ecological preparations, and biological feed products. Its core portfolio includes probiotics, enzyme preparations, and functional premixes designed to enhance livestock immunity, improve feed conversion rates, and promote sustainable farming practices. By leveraging biotechnology, the firm provides integrated solutions for the aquaculture and animal husbandry sectors, emphasizing scientific innovation and product quality to support the modernization of the agricultural supply chain.

Recent filings

Filing Released Lang Actions
山西大禹生物工程股份有限公司2026年第一次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2026 first extraordinary general meeting of shareholders of Shanxi Dayu Bioengineering Co., Ltd. It includes information about the meeting date, attendance, voting results on various proposals, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the official voting results and decisions made by shareholders during the meeting, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 1950 characters, which is typical for a voting results announcement rather than a full report or presentation. There is no indication that this is a report publication announcement or a regulatory filing. Therefore, the correct classification is DVA with high confidence.
2026-01-13 Chinese
上海市锦天城律师事务所关于山西大禹生物工程股份有限公司2026年第一次临时股东会的法律意见书
Regulatory Filings Classification · 80% confidence The document is a legal opinion letter (“法律意见书”) issued by a law firm regarding the convening, procedures, attendance and voting results of an extraordinary shareholders’ meeting. It does not itself announce the timing of a report nor present financial statements; it is not a management discussion (MDA), proxy solicitation (PSI), or simply a declaration of voting results by the company. Instead, it serves as a lawyer’s certification and legal attestation regarding compliance with laws and the company’s articles in holding the meeting. Under the certification rule, attestation or opinion letters belong in Regulatory Filings (RNS).
2026-01-13 Chinese
关于召开2026年第一次临时股东会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a notice for convening the 2026 first extraordinary general meeting of shareholders (临时股东会通知公告) of Shanxi Dayu Bioengineering Co., Ltd. It includes details about the meeting date, voting methods (onsite and online), agenda items to be voted on, registration procedures, and proxy authorization forms. The document does not contain financial statements or results but is an announcement about the meeting and voting process. It is not an annual report, earnings release, or management report. It is not a declaration of voting results but a notice of the meeting itself. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings, including notices of meetings.
2025-12-25 Chinese
关于2026年度公司与子公司相互提供银行融资相关担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shanxi Dayu Biological Engineering Co., Ltd. regarding the company's and its subsidiaries' mutual provision of bank financing guarantees for the year 2026. It includes detailed descriptions of the guarantee arrangements, involved parties, credit status, risk disclosures, and board resolutions approving the guarantees. The document is a formal announcement of a corporate financing-related guarantee arrangement, not a financial report or audit. It does not contain financial statements or earnings data but rather details a capital/financing update related to guarantees. The document length is 4334 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-12-25 Chinese
国投证券股份有限公司关于山西大禹生物工程股份有限公司部分募投项目结项并将节余募集资金永久补充流动资金的核查意见
Regulatory Filings Classification · 78% confidence The document is a sponsor (保荐机构) verification opinion on the conclusion of certain fund‐raising investment projects and the permanent transfer of surplus raised funds to working capital for Shanxi Dayu Bioengineering Co., Ltd., filed to the Beijing Stock Exchange. It contains detailed compliance review, project status, account balances, board resolutions, and the sponsor’s no‐objection opinion. This is neither an annual or interim report, nor an earnings release, nor a capital market transaction announcement. It is a regulatory compliance filing submitted under exchange rules. It does not simply announce that a report is available, nor is it a financial statement audit report of the company’s full books. Therefore it falls under the general “Regulatory Filings” (RNS) category as a compliance document.
2025-12-25 Chinese
国投证券股份有限公司关于山西大禹生物工程股份有限公司2026年度开展套期保值业务的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from a sponsoring securities company regarding the verification and opinion on the hedging business activities planned by Shanxi Dayu Bioengineering Co., Ltd. for the year 2026. It includes purpose, scope, risk analysis, risk control measures, accounting policies, and approval procedures related to the hedging business. The document is not an announcement of a report publication but contains substantive content about the company's business activities and risk management. It is not a financial statement or earnings release but a specialized report on hedging business and related risk controls, which aligns with an Audit Report / Information (AR) category, as it involves verification and opinions by the sponsoring institution on a specific business activity and its compliance with regulations. The document length is 2561 characters, which is sufficient for a detailed report but not a full annual or interim report. Therefore, the best fit is AR (Audit Report / Information). FY 2026
2025-12-25 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.